2. Terminology
Coats (1906) described new vessel formation on the iris in eyes with CRVO. This
neovascularisation is known as rubeosis iridis.
RI is associated with a severe form of glaucoma
Called as : Congestive G, Thrombotic G, Vascular G, Haemorrhagic G
Weiss and colleague proposed : Neovascular Glaucoma or Rubeotic Glaucoma
4. Theories of Neovascularisation
Retinal Hypoxia
Angiogenesis Factors : ocular tissues have angiogenic activity related to a key
angiogenic peptide, Vascular Endothelial Growth Factor (VEGF).
o VEGF : primary source is from Mϋller cells. Has 4 isoforms (VEGF121 , VEGF165 ,VEGF189
, VEGF206 ). It is a potent angiogenic stimulator, promoting proliferation, migration,
proteolytic activity, and capillary tube formation.
Vasoinhibitory Factors : Possible source from vitreous and lens.
6. Prerubeosis Stage : DM
Risk is RI in Dm is greatly increased when arteriolar or capillary nonperfusion is
present or after vitrectomy or lensectomy.
Fluorescence angiography : peripapillary leakage
Important to pay close attention to the papillary margin of iris, neovascularisation
is first seen here.
7. Prerubeosis Stage : CRVO
Develops hypotony
Fluorescein angiography reveals abnormal, leaking vessels in virtually all eyes
with extensive retinal capillary closure after CRVO.
Aqueous protein and cells concentration shows severity : Laser flare cell meter
RAPD
Most diagnostic finding : ERG
ERG finding : B-wave implicit time delay and a reduced B-wave A-wave
amplitude ratio.
Blood flow velocity : Color Doppler Imaging.
8.
9. Preglaucoma Stage :Rubeosis Iridis
Characterised by normal IOP, unless pre-existing COAG presents
Slitlamp : dilated tufts of preexiting capillaries and fine, randomly oriented vessels
on the surface of the iris near the pupillary margin
Leakage of fluorescein : New vessels
Peripupillary iris : first sight to be seen with Neovascularisation.
Gonioscopy : angle neovacularisation, single vascular trunks crossing the ciliary
body band and scleral spur and arborizing on the TM.
10.
11. Preglaucoma Stage :Rubeosis Iridis
HISTOPATHOLOGICAL FEATURES : begins intrastromally and then reaches on
the surface of the iris. New vessels in the angle run circumferentially in the TM,
with branches coursing into the Schlemm canal and occasionally into collector
channels
These new vessels have fenestrated walls are arranged in irregular patterns.
Ultrastructure of iris neovascularisation : Interendothelial cell junctions, attenuated
intraendothelial cytoplasm and pericyte formation.
12. Open Angle Glaucoma Stage
Doesn’t invariably follow the development of rubeosis iridis.
May resolve spontaneously in DR, with incidence of 13 to 41%
CRVO has higher incidence, typically occurs 8 to 15 weeks after the vascular
occlusive event. It has been called as 90 day glaucoma.
RI is more florid in this stage.
In Gonioscopy , AC angle is still open, but neovascularisation may be intense.
13. Open Angle Glaucoma Stage
Histopathological features : Hallmark is
fibrovascular membrane that covers the AC
angle and anterior surface of the iris and
may even extend to the posterior iris.
Glaucoma occurs d/t obstruction of the TM
by the fibrovascular membrane, with variable
contribution from the inflammation and
haemorrhage.
Spaced between the trabecular beams were
lined by a single layer of vascular
endothelium and were filled with RBCs.
14. Angle Closure Glaucoma Stage
Stroma of the iris has become flattened , with a smooth,glistening appearance .
Ectropion uveae is frequently present.
Iris is dilated and pulled anteriorly from the lens.
Contracture leads to formation of peripheral anterior synechia.
15. Open Angle Glaucoma Stage
Histological feature : alterations of the angle from the contracture of tissue
overlying these structures.
Tissue contraction : superficial layer of myofibroblasts (i.e, fibroblastic cells with
smooth muscle differentiation)
16. Management
Panretinal Photocoagulation
• Ablation of the peripheral retina with laser (argon) is the first line therapy.
• Significant to reduce or eliminate anterior segment neovascularisation.
• Mechanism : Uncertain , related to decreasing the retinal oxygen demand
• Reduce the stimulus for release of an angiogenesis factor or may reduce the
hypoxia in the anterior ocular segment
• Indicated in all cases of RI
• Photocoagulation should be performed in prerubeosis stage.
18. Management
Anti-VEGF Agents : Bevacizumab (1.25mg) in the vitreous cavity and (1.0-1.25
mg) in the anterior chamber
Seems to show significant regression of a concomitant reduction in IOP.
Important to proceed with PRP as soon as practical to help prevent recurrent
neovascularisations
19. Glaucoma surgical procedures
Cyclodestructive surgery : transscleral Nd:YAG cyclophotocoagulation and diode
laser cyclophotocoagulation
Filtering surgery : Rare successful,
Glaucoma Drainage device surgery : Encouraging results with adjuvant
bevacizumab.
Endoscopic cyclophotocoagulation
Silicone oil injection
IV injection of crystalline triamcinolone acetonide.
20. Reference:
1.Glaucoma – Shield Textbook of Glaucoma 6th edition
2.Curbside Consultation in Glaucoma : Steven J. Gedde
3.Myron yanoff and jay s duker4th edition
THANK YOU